Introduction
During the 1980s the incidence of infections with Neisseria gonorrhoeae has either declined or remained stable in several countries of the developed world.'-3 In developing countries, however, there are indications, such as the increased isolation of penicillinase prbducing N gonorrhoeae (PPNG) strains, that the incidence of gonococcal infection is increasing. It is difficult to ascertain the magnitude of the problem in these countries for various reasons. The absence of active surveillance and case finding activities, lack of treatment, self treatment, and a tendency to concentrate investigations on specific prostitute populations or on urban populations all contribute to appreciable under-reporting of cases. In addition, though many developing countries maintain statistical data on notifiable diseases such as gonorrhoea and syphilis, detailed information regarding these statistics is often not available to groups such as the World Health Organisation or the Pan American Health Organisation. 4 The above circumstances typify the situation in many Latin American countries.
In Chile, gonorrhoea is a notifiable disease. In 1982 the incidence of gonorrhoea was reported to be 100.8 cases per 100 000 people.5 This incidence has not changed appreciably since 1979 (when there were 98-4 cases per 100 000) when national statistics were collected for the first time. Before 1979 statistics had been maintained for only metropolitan areas. In 1964 the incidence of gonorrhoea in metropolitan areas of Chile per 100 000 was 134-9, whereas in 1982 it was 96-4. It should be noted that the national incidence in Chile is well below that cited by countries such as IndentgfYcation ofPPNG in Chile duing study ofgonococcal susceptibility to antimicrobials Canada and Sweden;' 2 though these figures may be severely underestimated due to incomplete reporting and undemotification of cases. 5 In Chile the primary regimen for treating uncomplicated acute gonorrhoea is penicillin (4.8 MIU aqueous procaine penicillin G, intramuscularly, with 1[0 g probenecid orally in a single dose) and the second line treatment is tetracycline (in an initial dose of 1 [5 g followed by 500 mg orally four times daily for four days).6 To ascertain whether treatment regimens are effective, it is essential to evaluate treatment success or failure with the in vitro susceptibility of the strains to antimicrobial agents. The present study was The Chilean Ministry of Health recommended treatment with 4-8 MIU aqueous procaine penicillin G by intramuscular injection plus 1 g oral probenecid as the first choice treatment for uncomplicated acute gonorrhoea. A tetracycline regimen ( 1 5 g followed by 500 mg four times daily for four days) was recommended as second choice. In the present study, the penicillin regimen was effective for 93'1 % ofthe cases treated, whereas tetracycline treatment was effective in 98.3% of the cases treated. Should the number of cases due to PPNG strains in Chile increase, penicillin treatment would be even less effective. A recent report by the World Health Organisation on treatments in the control of sexually transmitted diseases states that regimens "achieving less than 95% cure rates have been historically associated with rapid increases in the prevalence of resistant organisms", and also that regimens with cure rates of 90-95% should be used with caution, as resistant isolates may be selected. '9 The treatment data from this study underline the correctness of these statements. With a cure rate of 931% after penicillin treatment, the presence of resistant isolates is predicted. These predictions were confirmed by in vitro studies that showed the presence ofPPNG isolates for the first time in Chile and showed that about 3% of the non-PPNG isolates were resistant to 0.5 mg/l penicillin. The treatment failure rates observed with penicillin resulted in a re-evaluation of treatment recommended by the Chilean Ministry of Health (tetracycline is now the first choice treatment for certain cases of acute uncomplicated gonorrhea).
Critical MICs of several antibiotics have been 
